SGMT - Sagimet Biosciences Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$8.00
DETAILS
HIGH:
$8.00
LOW:
$8.00
MEDIAN:
$8.00
CONSENSUS:
$8.00
UPSIDE:
24.42%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 22.82 |
| Quick Ratio | 22.82 |
| Solvency Ratio | -10.005 |
| Cash Ratio | 6.87 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-3.75
Peer avg not available.
|
| PEG Ratio | -0.42 |
| Forward PEG | -0.42 |
| Price/Book | 1.72 |
| Price/Sales | 0.00 |
| Price/FCF | -4.19 |
| Price/Op Cash Flow | -4.19 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0007 |
| Debt/Equity | 0.0007 |
| Debt/Capital | 0.0007 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.05 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -8.949 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 100.0% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -729.35 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -585.26 |
| Operating Cash Flow Coverage | -585.26 |
| Capital Expenditure Coverage | 0.00 |
| Dividend + Capital Expenditure Coverage | 0.00 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -1.578 |
| Debt/Share | 0.0024 |
| Cash/Share | 3.50 |
| Book Value/Share | 3.44 |
| Tangible BV/Share | 3.44 |
| Equity/Share | 3.44 |
| Operating Cash Flow/Share | -1.411 |
| Capital Expenditure/Share | 0.000 |
| FCF/Share | -1.411 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.897 |
| Price/Fair Value | 1.72 |
| Debt/Market Cap | 0.0004 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -2.75 |